TruScreen Group Limited (TRU.AX)
ASX · AUD · Healthcare · Medical Devices
A$0.008 (+0.00%) as of
Key statistics
- Market cap
- 8.38M
- EPS (TTM)
- -0.0000
- Dividend yield
- 0.00%
- 52-week range
- 0.0080 – 0.0250
- Beta
- -0.06
- Revenue (TTM)
- 2.82M
- Profit margin
- -79.78%
- Analyst target
- A$0.024
- Volume
- 1.25k
About TruScreen Group Limited
TruScreen Group Limited, together with its subsidiaries, develops, manufacture, and sale of cancer detection devices and systems in Mexico, China, Central Asia, Vietnam, Zimbabwe, Indonesia, India, and the Middle East/North Africa. It offers TruScreen cervical cancer screening device, a medical device for identifying and detecting the presence of precancerous and cancerous tissue on the cervix in real time. The company was formerly known as TruScreen Limited and changed its name to TruScreen Group Limited in August 2020. TruScreen Group Limited was incorporated in 2013 and is headquartered in Auckland, New Zealand.
- Sector
- Healthcare
- Industry
- Medical Devices
- Headquarters
- Auckland, New Zealand
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.